Wellness supplements are essential for maintaining a healthy life. Supplements contain all the minerals in ample amount to meet the daily requirement for healthy life. Food supplement usually ...
Report Code : A05269 | Category : Life Sciences
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
The global size was $58 million in 2018, and is projected to reach $82 million by 2026, growing at a CAGR of 4.7% from 2019 to 2026.
Report Code : A05280 | Pages : 268 | Category : Life Sciences
Animal identification tags is a process used to identify and track specific animals. The tagging of animals is done due to various reasons such as biosecurity control, research ...
Report Code : A05286 | Category : Life Sciences
Bioprocess containers are single-use, flexible containers system widely incorporated for handling sterile liquids. Moreover, these containers are employed for vaccine manufacturing and media preparation in the biopharmaceutical industry. ...
Report Code : A05288 | Category : Life Sciences
Gastroesophageal reflux disease (GERD) is a digestive disorder, which is caused when stomach contents such as acid, food, and fluids reflux to the esophagus. This causes irritation of ...
Report Code : A05289 | Category : Life Sciences
The global lysosomal disease treatment market was valued at $7.6 billion in 2021, and is projected to reach $14.1 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031.
Report Code : A05290 | Pages : 319 | Category : Life Sciences
Precision medicine is an emerging medical approach undertaken by medical practitioners for the treatment of a patient, followed with medical decisions, treatments, practices, or products being tailored to ...
Report Code : A05310 | Category : Life Sciences
Gene editing, or genome editing, is a type of genetic engineering in which with the help of engineered nucleases, DNA is inserted, deleted, or replaced in the genome ...
Report Code : A05312 | Category : Life Sciences
The global mental health software market was valued at $4.8 billion in 2023, and is projected to reach $14.6 Billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033
Report Code : A05457 | Pages : 216 | Category : Life Sciences
The global medical display market was valued at $2,052.77 million in 2019, and is projected to reach $3,194.72 million by 2027, registering a CAGR of 4.90% from 2020 to 2027.
Report Code : A05704 | Pages : 268 | Category : Life Sciences
The global healthcare chatbots market accounted for $116.9 million in 2018 and is expected to reach $345.3 million by 2026, registering a CAGR of 14.5% from 2019 to 2026.
Report Code : A05811 | Pages : 184 | Category : Life Sciences
The global medical cooling system market size was valued at $610.3 in 2018 and is expected to reach $828.8 million by 2026, registering a CAGR of 3.9% from ...
Report Code : A05842 | Pages : 255 | Category : Life Sciences
The top 10 cancer drugs market size was valued at $77.9 billion in 2022 and is estimated to reach $198.8 billion by 2032, exhibiting a CAGR of 10.0% ...
Report Code : A05860 | Pages : 190 | Category : Life Sciences
The global LFIA based rapid test market was valued at $4,725 million in 2018, and is projected to reach $8,494 million by 2026, registering a CAGR of 7.6% from 2019 to 2026.
Report Code : A05863 | Pages : 393 | Category : Life Sciences
The global pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is projected to reach $855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.
Report Code : A05875 | Pages : 195 | Category : Life Sciences
The global veterinary CRO market was valued at $577.20 million in 2020 and is projected to reach $1,175.72 million by 2030 registering a CAGR of 7.7% from 2021 ...
Report Code : A05900 | Pages : 231 | Category : Life Sciences
The global antifibrinolytic drugs market was valued at $13,593 million in 2018 and is expected to reach $19,333 million by 2026, registering a CAGR of 4.5% from 2019 to 2026.
Report Code : A05914 | Pages : 165 | Category : Life Sciences
The global antihyperlipidemic drugs market accounted for $9,456 million in 2018, and is expected to reach $16,865 million by 2026, registering a CAGR of 7.5% from 2019 to 2026.
Report Code : A05919 | Pages : 184 | Category : Life Sciences
The global nephrology devices market accounted for $12,012 million in 2018 and is expected to reach $16,421 million by 2026, registering a CAGR of 4.0% from 2019 to 2026.
Report Code : A05921 | Pages : 166 | Category : Life Sciences
The global immunosuppressants market size was valued at $13,890.0 million in 2018 and is expected to reach $42,511.37 million by 2026, registering a CAGR of 14.7% from 2019 to 2026.
Report Code : A05923 | Pages : 165 | Category : Life Sciences
The global anti-rheumatics market accounted for $57,229 million in 2018 and is expected to reach $71,934 million by 2026, registering a CAGR of 2.9% from 2019 to 2026.
Report Code : A05924 | Pages : 202 | Category : Life Sciences
The hybrid operating room market was valued at $744 million in 2018, and is estimated to reach at $1,804 million by 2026, registering a CAGR of 11.7% from 2019 to 2026.
Report Code : A05929 | Pages : 245 | Category : Life Sciences
The global workplace wellness market size was valued at $49.81 billion in 2019, and is projected to reach $66.20 billion by 2027, registering a CAGR of 5.9% from 2020 to 2027.
Report Code : A05935 | Pages : 164 | Category : Life Sciences
The global alopecia treatment market was valued at $2,736 million in 2018, and is projected to reach $3,935 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A05945 | Pages : 243 | Category : Life Sciences
